Frontlight ResearchEarly access
Trial site
People's Hospital of Tianjin
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Type 2 diabetes2 trials
- Acute myeloid leukaemia1 trial
- Follicular lymphoma1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 36 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed4 trials
- Not yet recruiting3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Shenzhen HighTide Biopharmaceutical Ltd.2 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- RemeGen Co., Ltd.1 trial
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1 trial
- and 2 more
Running trials
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Follicular lymphoma1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Terminated
Completed
Completed
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026